https://doi.org/10.31288/oftalmolzh201421016

Dynamics of clinical changes in patients with kerato-conjunctivitis influenced by thiol drugs

Mohamed Abdulrahman Kutaini

Lugansk State Medical University, Lugansk (Ukraine)

Key words: keratitis, conjunctivitis, thiol drugs

Introduction. Kerato-conjunctivitis is a severe pathology, so search for the new ways and methods of treatment of this disease is still one of the urgent problems of ophthalmology

Materials and Methods: There were examined 95patients. The first group (con¬trol) included 45 patients with kerato-conjunctivitis treated only with conventional therapy. The second group (basic) — 50patients with kerato-conjunctivitis who received thiol drugs in addition to the primary therapy.

Results: While analysing the results of treatment, severity of corneal edema during the first observation period was reduced by 32 %, in the second period — 42 %, in the third period — 30 %. Intensity of inflammatory infiltration in the first observation period was reduced by 23 %, in the second period — 42 %, in the third — 25 %. Intensity of corneal staining with fluorescein in the study group after treatment during the first observation was reduced by 10 %, in the second period — 20 %, in the third — 18 % compared with the control group.

Conclusion: The results of clinical studies indicate that the inclusion of thiol drugs in the complex treatment of patients with kerato conjunctivitis significantly reduces the severity of clinical symptoms and allows to stop the disease process in the cornea in shorter time.

References

1.Anina Yel. Incidence of the corneal diseases in population of Ukraine. Thesis of II International conference of ophthalmologists of Black Sea area. Odessa; 2004. 14. Russian.

2.Gundorova RA, Makarov PV, Dadasheva ZR. Dry eye syndrome treatment in eye burns. Klinich. Oftalmol. 2003;4(1):10-2. Russian.

3.Gyurdzhyan TA. New aspects of therapeutical therapy in eye inflammations. Thesis of VII Congress of ophthalmologists of Russia. Part II. Moscow. 2000. 144- 5. Russian.

4.Dembskii LK, Shirshova ON, Mironyuk OV. Some aspects of the organization of the treatment of viral keratitis. Pro-ceedings of I Scient. Pract. Conf. K.; 2004. 99- 100. Rus¬sian.

5.Drozhzhina GI. Viral diseases of the cornea and conjunc¬tiva. Zdorovia Ukrainy. 2002;5:35-6.

6.Kamenskaya EV. Effectiveness of drug correction of vio-lations of the thiol status of superficial forms of herpetic keratitis: author's thesis of Candidate of Med.Science: 14.01.18 Ophthalmology. Odessa. 2008. 20 p.

7.Maichuk YuV. Prevention of blindness as a result of corneal pathologies. Vestn Oftalmol. 1990;3:58- 60. Russian.

8.Ostashevskii VL. The therapeutic effect of protease inhibi¬tors in purulent ulcerative keratitis: author's thesis of Candidate of Medical Science. 14.01.18. Odessa. 1983. 23 p.

9.Petrunya AM, Mukhamed Abdulrakhman Kutaini. The study of metabolic processes in the cornea in experimental keratitis and conjunctivitis. Problemy ekologichnoi ta medich-noi genetiki I klinichnoi imunologii. 2012;3(111):205- 21. Russian

10.Petrunya AM, Mukhamed Abdulrakhman Kutaini. Study of thiol exchange and redox processes in the cornea in experimental conjunctivitis. Problemy ekologichnoi ta medich-noi genetiki I klinichnoi imunologii. 2012;1(109):259- 72. Russian

11.Saldan IR, Prysyazhna MV, Saldan Yul. Amniotic mem-brane transplantation for diseases of the anterior segment of the eye in the experiment. Visnyk morfologii VNMU im. Pirogova. 2003;2:237-8. Ukrainian.

12.Saporovskii SS, Zabaikina TP, Pukhova SI. Features of treatment of bacterial keratitis and corneal ulcers. VIII Congress of Ophthalmologists of USSR: thesis. Odessa.

1990. 325-6.

13.Sergiyenko MM, Rykov SO, Ferfilfain IL. The organization of eye care, disease and disability caused by disease of the eye in Ukraine. Thesis and lectures of II conf. of Pediatric ophthalmologists of Ukraine. Kyiv: KVTs. 2003. 299-315.

14.Stepanenko GV, Yavtushenko VF, Lupyr SA, Petrunya OM. Clinical and epidemiological features of herpetic keratitis patients in an industrial region. Thesis of X Con¬gress of ophthalmologists of Ukraine. Odessa. 2002. 58.

15.Sudalin AV, Batmanov YuE. Application of keratoplasty and conjunctiva plasty in the treatment of deep keratitis. Klin Oftalmol. 2003:4(1):1- 3. Russian.

16.Cherednichenko ML, Podsvirova OA. Our experience of treating corneal opacities. Thesis of scientific conference of ophthalmologists. Odessa. 2000. 42-4.

17.Abu el-Asrar AM, Geboes K, Tabbara KF. Immunopatho-genesis of vernal keratoconjunctivitis. Bull Soc Belge Ophthalmol. 1996; 261:15-24.

18.Bourcier T, Thomas F, Borderie V. Bacterial keratitis: pre-disposing factors, clinical and microbiological review of 300 cases. Br. J. Ophthalmol. 2003;87:834- 8.
Crossref   Pubmed

19.Limberg MB. A review of bacterial keratitis and bac¬terial conjunctivitis. Am J Ophthalmol. 1991;112 (4 Suppl):2S — 9S.

20.Mittelviefhaus H, Auw-Hadrich C. Corneal complications after hematopoietic stem cell transplantation. Ophthalmologe. 2003;100:222-9.
Crossref   Pubmed

21.Nakamura T, Nishida K, Dota A. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest. Ophthalmol. Vis. Sci. 2001;42:549-56.

22.Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplatation for persistent corneal epithelial defect with and without stromal thinning

and perforation. Br. J. Ophthalmol. 2001;85(12):1455-63.
Crossref